Agenus (FRA:AJ8) Purchase Of Property, Plant, Equipment : €-7.6 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Agenus Purchase Of Property, Plant, Equipment?

Agenus's purchase of property, plant, equipment for the three months ended in Mar. 2024 was €-0.0 Mil. It means Agenus spent €0.0 Mil on purchasing property, plant, equipment. Agenus's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2024 was €-7.6Mil.

Compared with last quarter (€-0.2 Mil in Dec. 2023 ), Agenus spent less money on purchasing property, plant, equipment in Mar. 2024 (€-0.0 Mil).

Agenus Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Agenus's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agenus Purchase Of Property, Plant, Equipment Chart

Agenus Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Property, Plant, Equipment

Get a 7-Day Free Trial

-4.19

-2.85

-29.93

-50.09

-9.13

Agenus Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Purchase Of Property, Plant, Equipment	Get a 7-Day Free Trial															-1.72	-4.10	-3.24	-0.20	-0.03

Agenus Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-7.6 Mil.

Agenus Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Agenus's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Agenus (FRA:AJ8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Agenus Inc (FRA:AJ8) » Definitions » Purchase Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

AGEN:USA AJ81:Germany

Address

3 Forbes Road, Lexington, MA, USA, 02421

Website

https://www.agenusbio.com

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

Agenus (FRA:AJ8) Headlines

No Headlines